Search Results - "HEATHCOTE, E. J."

Refine Results
  1. 1

    Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis by Poupon, RE, Lindor, KD, Cauch-Dudek, K, Dickson, ER, Poupon, R, Heathcote, EJ

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-1997)
    “…BACKGROUND & AIMS: Long-term ursodeoxycholic acid (UDCA) therapy slows the progression of primary biliary cirrhosis. This study examined the effect of UDCA…”
    Get full text
    Journal Article
  2. 2

    Polymorphisms of HLA‐DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B by Brouwer, W. P., Sonneveld, M. J., Tabak, F., Simon, K., Cakaloglu, Y., Akarca, U. S., Zeuzem, S., Ferenci, P., Heathcote, J. E., Knegt, R. J., Boonstra, A., Hansen, B. E., Janssen, H. L. A.

    Published in Alimentary pharmacology & therapeutics (01-10-2014)
    “…Summary Background Polymorphisms of the HLA‐DP gene are associated with the natural clearance of the hepatitis B virus in Asian patients. Aim To investigate…”
    Get full text
    Journal Article
  3. 3

    Fatigue in primary biliary cirrhosis by Cauch-Dudek, K, Abbey, S, Stewart, D E, Heathcote, E J

    Published in Gut (01-11-1998)
    “…Background—Fatigue is a frequent and debilitating symptom in patients with primary biliary cirrhosis (PBC). Aims—To study fatigue in relation to sleep,…”
    Get full text
    Journal Article
  4. 4

    Histological benefits of virological response to peginterferon alfa‐2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis by EVERSON, G. T., BALART, L., LEE, S. S., REINDOLLAR, R. W., SHIFFMAN, M. L., MINUK, G. Y., POCKROS, P. J., GOVINDARAJAN, S., LENTZ, E., HEATHCOTE, E. J.

    Published in Alimentary pharmacology & therapeutics (01-04-2008)
    “…Summary Background  Patients with chronic hepatitis C virus and advanced fibrosis or cirrhosis are at risk for disease progression and hepatic decompensation…”
    Get full text
    Journal Article
  5. 5

    Epidemiology of autoimmune liver disease by FELD, JJ, HEATHCOTE, EJ

    Published in Journal of gastroenterology and hepatology (01-10-2003)
    “…Primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) are chronic liver diseases that likely have an autoimmune…”
    Get full text
    Journal Article
  6. 6

    Fatigue in chronic cholestasis by Milkiewicz, P, Heathcote, E J

    Published in Gut (01-04-2004)
    “…Fatigue is probably the most intriguing symptom affecting patients with chronic cholestatic disorders, in particular those with primary biliary cirrhosis. It…”
    Get full text
    Journal Article
  7. 7

    Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection? by Bressler, B, Pinto, R, El-Ashry, D, Heathcote, E J

    Published in Gut (01-03-2005)
    “…Background: Recent guidelines from an AASLD Single Topic Symposium suggest that patients with cirrhosis, including those with primary biliary cirrhosis (PBC)…”
    Get full text
    Journal Article
  8. 8

    Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis by Springer, J, Cauch-Dudek, K, O'Rourke, K, Wanless, I R, Heathcote, E J

    Published in The American journal of gastroenterology (01-01-1999)
    “…To document the natural history of asymptomatic primary biliary cirrhosis and identify prognostic features that would predict the development of symptomatic…”
    Get full text
    Journal Article
  9. 9

    Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B by Villeneuve, Jean‐Pierre, Condreay, Lynn D., Willems, Bernard, Pomier‐Layrargues, Gilles, Fenyves, Daphna, Bilodeau, Marc, Leduc, Raymond, Peltekian, Kevork, Wong, Florence, Margulies, Mariana, Heathcote, E. Jenny

    Published in Hepatology (Baltimore, Md.) (01-01-2000)
    “…The prognosis of decompensated cirrhosis resulting from chronic hepatitis B is poor, and the benefits of treatment with interferon are outweighed by serious…”
    Get full text
    Journal Article
  10. 10

    Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis by Michieletti, P, Wanless, I R, Katz, A, Scheuer, P J, Yeaman, S J, Bassendine, M F, Palmer, J M, Heathcote, E J

    Published in Gut (01-02-1994)
    “…This study reports on a group of 20 patients with an initial diagnosis of primary biliary cirrhosis (PBC) whose serum tested negative for antimitochondrial…”
    Get full text
    Journal Article
  11. 11

    Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance by Moskovitz, D. N., Osiowy, C., Giles, E., Tomlinson, G., Heathcote, E. J.

    Published in Journal of viral hepatitis (01-07-2005)
    “…Lamivudine is effective in suppressing viral replication, normalizing alanine aminotransferase (ALT), and improving histological appearance in HBe positive and…”
    Get full text
    Journal Article
  12. 12

    Hepatitis C–Related Cirrhosis: A Predictor of Diabetes After Liver Transplantation by Bigam, Dave L., Pennington, Jason J., Carpentier, Andre, Wanless, Ian R., Hemming, Alan W., Croxford, Ruth, Greig, Paul D., Lilly, Leslie B., Heathcote, Jenny E., Levy, Gary A., Cattral, Mark S.

    Published in Hepatology (Baltimore, Md.) (01-07-2000)
    “…Hepatitis C virus (HCV) infection has recently been suggested to be a risk factor for the development of diabetes mellitus. The aim of our study was to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Serum cytokine values and fatigue in chronic hepatitis C infection by Gershon, A. S., Margulies, M., Gorczynski, R. M., Heathcote, E. J.

    Published in Journal of viral hepatitis (01-11-2000)
    “…Patients with chronic hepatitis C infection often experience fatigue. In many clinical situations, an association between fatigue and altered serum cytokine…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis by Züchner, D, Sternsdorf, T, Szostecki, C, Heathcote, E J, Cauch‐Dudek, K, Will, H

    Published in Hepatology (Baltimore, Md.) (01-11-1997)
    “…Antinuclear antibodies (ANA) staining nuclear dot structures predominantly occur in primary biliary cirrhosis (PBC) patients and recognize the Sp100 and…”
    Get full text
    Journal Article
  17. 17

    Detection of occult low‐grade B‐cell non‐hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia by Rasul, Imran, Shepherd, Frances A., Kamel‐Reid, Suzanne, Krajden, Mell, Pantalony, Dominic, Heathcote, E. Jenny

    Published in Hepatology (Baltimore, Md.) (01-02-1999)
    “…Hepatitis C virus (HCV) is both hepatotropic and lymphotropic and has been shown to be associated with the benign lymphoproliferative disorder, mixed…”
    Get full text
    Journal Article
  18. 18

    Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis? by COMAY, D, CAUCH-DUDEK, K, HEMPHILL, Doug, DIAMANDIS, E, WANLESS, I, HEATHCOTE, E. J

    Published in Digestive diseases and sciences (01-10-2000)
    “…Antibodies to carbonic anhydrase II (CAII) have been reported to be specific to anti-mitochondrial antibody (AMA)-negative primary biliary cirrhosis (PBC). We…”
    Get full text
    Journal Article
  19. 19

    Management of primary biliary cirrhosis by Heathcote, E. Jenny

    Published in Hepatology (Baltimore, Md.) (01-04-2000)
    “…Primary biliary cirrhosis (PBC) is a presumed autoimmune disease of the liver, which predominantly affects women once over the age of 20 years. Most cases are…”
    Get full text
    Journal Article
  20. 20